Some Recent Publications

2002

• Cantor SB. Pharmacoeconomics of coxib therapy. J Pain Symptom Manage 2002; 24:S28-S37.

• Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ. Psychological benefits of prostate cancer screening: the role of reassurance. Health Expectations 2002; 5:104-113.

• Elting LS, Cantor SB. Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices. Supportive Care in Cancer 2002; 10(3):189-196.

• Elting LS, Cantor SB, Martin CG, Hamblin L, Kurtin DJ, Rivera E, Vadhan-Raj S, Benjamin RS. Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors. Cancer (in press).

• Elting LS, Martin CG, Kurtin DJ, Cantor SB, Rubenstein EB, Rodriguez S, Kanesan K, Vadhan-Raj S, Benjamin RS. The bleeding risk index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors. Cancer 2002; 94:3252-3262.

• Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20:4361-4367.

• Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 2002; 94(1):197-204.

• Shureiqi I, Cantor SB, Lippmann SM, Brenner DE, Chernew ME, Fendrick AM. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy. British Journal of Cancer 2002; 86(2):226-232.

2001

• Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 2001; 130(6):921-930.

• Elting LS, Rubenstein EB, Kurtin D, Martin CG, Rodriguez S, Cantor SB, Laiho E, Kanesan K, Benjamin RS. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 2001; 19(4):1137-1146.

• Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 2001; 92(4):863.868.

2000

• Cantor SB, Kattan MW. Determining the area under the ROC curve for a binary diagnostic test. Med Decis Making 2000; 20(4):468-470.

• Elting LS, Rubenstein EB, Rolstson K, Cantor SB, Martin CG, Kurtin D, Rodriguez S, Lam T, Kanesan K, Bodey GP. Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care. J Clin Oncol 2000; 18(21):3699-3706.

• Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage 2000; 20(5):318-325.

• Ganiats TG, Carson RT, Hamm RM, Cantor SB, Sumner W, Spann SJ, Hagen MD, Miller CM. Population-based time preferences for future health outcomes. Med Decis Making 2000; 20(3):263-270.

• Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost-effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum 2000; 43(12):1695-1703.

1999

• Cantor SB, Ganiats TG. Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. J Clin Epidemiol 1999; 52(6):517-522.

• Cantor SB, Sun CC, Tortolero-Luna G, Richards-Kortum R, Follen M. A comparison of C/B ratios from studies using receiver operating characteristic curve analysis. J Clin Epidemiol 1999; 52(9):885-892.

• Elting LS, Martin CG, Cantor SB, Rubenstein EB. Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures. BMJ 1999; 318(7197):1527-1531.

• Kattan MW, Fearn PA, Cantor SB, Hu J, Cowen ME, Giesler RB, Miles BJ. Telephone interviews vs. workstation sessions for acquiring quality of life data. Proc AMIA Symp 1999; 23:296-300.

• Mitchell MF, Cantor SB, Ramanujam N. Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999; 93(3):462-470.

• Mitchell MF, Cantor SB, Brookner C, Utzinger U, Schottenfeld D, Richards-Kortum R. Screening for squamous intraepithelial lesions with fluorescence spectroscopy. Obstet Gynecol 1999; 94(5 Pt 2):889-896.

• Utzinger U, Trujillo EV, Atkinson EN, Mitchell MF, Cantor SB, Richards-Kortum R. Performance estimation of diagnostic tests for cervical precancer based on fluorescence spectroscopy: effects of tissue type, sample size, population and signal-to-noise ratio. IEEE Trans Biomed Eng 1999; 46(11):1293-1303.